ENTX

Entera Bio Ltd.

Healthcare · Biotechnology

$132.67 sample

-0.61 (-0.46%) 1D

Market cap

$463.4B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-09

Alerts

8

Price$132.67 +3.39% 3M daily closessample

134.44123.58

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider sell: General Counsel
Oct 05INSInsider sell: 10% owner
Sep 25INSInsider sell: EVP, Operations
Sep 17INSInsider sell: Chief Executive Officer
Sep 09SECDEF 14A filed
Sep 04INSInsider buy: General Counsel
Aug 26INSInsider sell: EVP, Operations
Aug 19INSInsider sell: Chief Executive Officer

Sign up to see the real ENTX record →

Company facts

SEC EDGAR registration

Name: Entera Bio Ltd.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +3sample, -100 to +100
Reporting currency: USD

Who is positioning in ENTX

sample

Insiders: 14 insider transactions over 90 days, net selling, $253.2M
Congress: 5 members traded over 90 days
Institutions · 13F: 35 funds hold $11.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$29.1B +19.0% y/y

Q4 2024Q3 2026

Inventory$16.2B +7.3% y/y

Q4 2024Q3 2026

Accounts receivable$12.9B +17.2% y/y

Q4 2024Q3 2026

Total debt$33.8B +7.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $249.3B -13.2% 3M
Sample peer B: $144.4B +10.2% 3M
Sample peer C: $264.0B -0.9% 3M
Sample peer D: $239.4B +8.4% 3M
Sample peer E: $225.3B +4.1% 3M